Peking University Cancer Hospital
Beijing, China
Key Insight: Supported by nearly 2,400 employees, including 124 full professors and 50 PhD supervisors. The hospital comprises 34 clinical, 14 medical technology, and 17 basic research departments, operating 9 pioneering disease-specific multidisciplinary tumor treatment (MDT) groups.
Pioneering Care &
Global Oncology Excellence
Peking University Cancer Hospital is a premier modern oncology specialist institution. Integrating advanced medical care, education, research, and cancer prevention, it is a national key discipline and a leading participant in formulating clinical guidelines for multiple cancers.
Aligned with the "Healthy China" strategy, it hosts academician-led teams in gastrointestinal and thoracic oncology. It delivers standardized, patient-centered comprehensive treatment and acts as the sole authorized institution providing cancer incidence and survival statistics for the Beijing region to the government and WHO.
Authorized Unit
Beijing Cancer Incidence Registration & Statistics Center
Institutional Status & External Evidence
National Key Disciplines & Specialties
Oncology (Core)
Holds over 100 ministerial/municipal research achievements; conducts extensive research on prevalent cancer mechanisms.
Pathology
National Clinical Key Specialty handling all tumor specimens, serving as the core support for precision oncology.
Gastric Cancer
Flagship discipline achieving domestic leadership and international excellence in surgical oncology and comprehensive treatment.
Breast Cancer Center
Dedicated to early screening, precision diagnosis, and individualized MDT-based full-course disease management.
Interventional Therapy
Beijing key discipline providing high-level minimally invasive treatment options for patients with unresectable tumors.
Integrative TCM Oncology
Focuses on palliative care and rehabilitation for elderly patients; houses a National Workshop for Renowned TCM Experts.
Medical & Research Innovation Hubs
International Medical Services
Peking University Cancer Hospital has been accelerating its internationalization, attracting clinical and research professionals worldwide, particularly from Belt and Road countries, for extensive exchange and training.
- Receives and treats patients from across China, Hong Kong, Macao, Taiwan, and international regions.
- Establishes close collaborative relationships with many internationally renowned cancer research institutions.
- Continuously enhances its multidisciplinary capabilities based on an internationally aligned quality management system.
Global Excellence Standard
With international experts and scholars visiting annually for research cooperation, the hospital continuously improves its multidisciplinary capabilities and positions itself as a top-tier internationalized cancer treatment center.
International Patient Capacity
Demonstrating comprehensive capability to serve global patients with standardized and individualized care.
Source & Verification
Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.